Article Details

MediLink Therapeutics closes US$70 million Series B financing - Benzinga

Retrieved on: 2022-03-14 19:24:26

Tags for this article:

Click the tags to see associated articles and topics

MediLink Therapeutics closes US$70 million Series B financing - Benzinga. View article details on hiswai:

Excerpt

SUZHOU, China, March 14, 2022 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., ... This round was led by LYFE Capital and Qiming Venture.

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up